| Pharmaceutical active ingredients: |
| Deferoxamine Mesylate |
| Available forms, composition and doses of PMS-Deferoxamine: |
| Injectable; Injection; Deferoxamine Mesylate 2 gInjectable; Injection; Deferoxamine Mesylate 500 mg |
| PMS-Deferoxamine medical category: |
| Human:AntidotesDetoxifying agents and drugs used in substance dependenceHeavy metal antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V03AC01 - Deferoxamine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pharmascience |